MEN1
Chr 11ADmenin 1
Also known as: MEAI, SCG2
This gene encodes menin, a tumor suppressor associated with a syndrome known as multiple endocrine neoplasia type 1. Menin is a scaffold protein that functions in histone modification and epigenetic gene regulation. It is thought to regulate several pathways and processes by altering chromatin structure through the modification of histones. [provided by RefSeq, May 2019]
Primary Disease Associations & Inheritance
Definitive — sufficient evidence for diagnostic panels
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly LoF-intolerant (top ~10% of genes)
Highly missense-constrained (top ~0.1%)
ClinVar Variant Classifications
700 submitted variants in ClinVar
Classification Summary
Curated Variants Distribution
Classified variants from ClinVar · 5 ACMG categories
| Classification | LoF | Missense + Inframe | Non-coding | Synonymous | Total |
|---|---|---|---|---|---|
Pathogenic | 65 | 4 | 26 | 0 | 95 |
Likely Pathogenic | 19 | 19 | 8 | 0 | 46 |
VUS | 6 | 267 | 20 | 4 | 297 |
Likely Benign | 0 | 3 | 66 | 120 | 189 |
Benign | 0 | 1 | 28 | 21 | 50 |
Conflicting | — | 23 | |||
| Total | 90 | 294 | 148 | 145 | 700 |
LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly
View in ClinVar →Protein Context — Lollipop Plot
MEN1 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
Gene2Phenotype Curations
MEN1-related multiple endocrine neoplasia
definitiveGene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org
OMIM — Genotype-Phenotype Relationships
2 OMIM entries
Adrenal adenoma, somatic
Molecular basis of disorder known
Angiofibroma, somatic
Molecular basis of disorder known
Carcinoid tumor of lung
Molecular basis of disorder known
Lipoma, somatic
Molecular basis of disorder known
Parathyroid adenoma, somatic
Molecular basis of disorder known
External Resources
Links to major genomics databases and tools
Variant Interpretation
Population Databases
Gene Resources
Expert Curation
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
RECRUITINGRevumenib in Combination With 7+3 + Midostaurin in AML
RECRUITINGFamilial Investigations of Childhood Cancer Predisposition
RECRUITINGRevumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
RECRUITINGSNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
RECRUITINGA Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
ACTIVE NOT RECRUITINGBleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
NOT YET RECRUITINGRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
RECRUITINGA Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
RECRUITINGFTT PET/CT in Pancreatic Neuroendocrine Tumors
RECRUITINGA Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RECRUITINGPrevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History
NOT YET RECRUITINGExternal Resources
Links to major genomics databases and tools